scholarly journals COVID-19 Clusters at Workplaces and its Transmission into Communities in Vietnam: A Novel Emerging Occupational Risk Factor at Work Due to Coronavirus Infection

2020 ◽  
Vol 3 (1) ◽  
pp. 27-33
Author(s):  
Nhi Ngoc Yen Huynh ◽  
Dai Duc Nguyen ◽  
Nguyen Ha Ta ◽  
Minh Thien Nguyen ◽  
Tai Van Nguyen ◽  
...  
Keyword(s):  
Risk Factor ◽  
Clinical Course ◽  
Close Contact ◽  
Occupational Risk ◽  
Ho Chi Minh City ◽  
Ministry Of Health ◽  
Occupational Risk Factor ◽  
Infection Age ◽  
Sources Of Infection ◽  
Coronavirus Infection

Aims: This study aimed to describe the characteristics of the workplace-related clusters of COVID-19 and its transmissions into communities in Vietnam. Methods and Material: We accessed the database of COVID-19 by the Ministry of Health, Vietnam. Variables included sources of infection, age, sex, nationality, the dates of onset of symptoms and discharge from hospitals, and ID of each patient tested positive with COVID-19. Information from each patient was linked to the sources of infection to identify workplace-related clusters. Among 314 patients, we excluded 43 cases related to two charter flights, the remaining 271 cases were eligible for the study.Results: The biggest cluster of hospital canteen included 26 workers and their 31 family members or hospital’s patients. The second biggest cluster included a pilot of the Vietnam airlines and other 16 patients who have close contact with him at the Bar Buddha at Ho Chi Minh City. A total of 87 patients (32.1% of 271 cases) were related to these workplace-related clusters. The suspected time and the clinical course was significantly longer in the workplace-related clusters than other patients (mean 6.52 vs. 4.05 days, p=0.0191) and (mean 28.71 vs. 20.52 days, p=0.0005), respectively. Conclusions: Because COVID-19 infection at workplaces was responsible for nearly one-third of the total patients, there was a novel emerged occupational risk factor at work due to coronavirus infection. Safety at the workplace in preventing COVID-19 transmission is highly needed.

scholarly journals Cold working environments as an occupational risk factor for COVID-19

2020 ◽  
Author(s):  
Louise Cunningham ◽  
Paul J Nicholson ◽  
Jane O’Connor ◽  
John P McFadden
Keyword(s):  
Risk Factor ◽  
Cold Working ◽  
Occupational Risk ◽  
Occupational Risk Factor ◽  
Working Environments

Polycyclic aromatic hydrocarbons and occupational risk factor

2008 ◽  
Vol 26 (1) ◽  
pp. 74 ◽  
Author(s):  
Elena Szabová ◽  
Dagmar Zeljenková ◽  
Eva Nesčáková ◽  
Milan Šimko ◽  
Ladislav Turecký
Keyword(s):  
Risk Factor ◽  
Polycyclic Aromatic Hydrocarbons ◽  
Aromatic Hydrocarbons ◽  
Occupational Risk ◽  
Occupational Risk Factor ◽  
Polycyclic Aromatic

scholarly journals In-plant noise as occupational risk factor at petrochemical plants

2017 ◽  
pp. 116-124 ◽  
Author(s):  
A.D. Volgareva ◽  
◽  
L.K. Karimova ◽  
L.N. Mavrina ◽  
Z.F. Gimaeva ◽  
...  
Keyword(s):  
Risk Factor ◽  
Occupational Risk ◽  
Occupational Risk Factor

scholarly journals IN-PLANT NOISE AS OCCUPATIONAL RISK FACTOR AT PETROCHEMICAL PLANTS

2017 ◽  
pp. 116-124 ◽  
Author(s):  
A.D. Volgareva ◽  
◽  
L.K. Karimova ◽  
L.N. Mavrina ◽  
Z.F. Gimaeva ◽  
...  
Keyword(s):  
Risk Factor ◽  
Occupational Risk ◽  
Occupational Risk Factor

Mechanisms of liver damage in COVID-19

2020 ◽  
Vol 1 (19) ◽  
pp. 39-46
Author(s):  
T. V. Pinchuk ◽  
N. V. Orlova ◽  
T. G. Suranova ◽  
T. I. Bonkalo
Keyword(s):  
Hepatocellular Carcinoma ◽  
Liver Transplantation ◽  
Risk Factor ◽  
Liver Disease ◽  
Liver Function ◽  
Liver Damage ◽  
The World ◽  
Coronavirus Infection ◽  
The Impact ◽  
Analyze Data

At the end of 2019, a new coronavirus (SARS-CoV-2) was discovered in China, causing the coronavirus infection COVID-19. The ongoing COVID-19 pandemic poses a major challenge to health systems around the world. There is still little information on how infection affects liver function and the significance of pre-existing liver disease as a risk factor for infection and severe COVID-19. In addition, some drugs used to treat the new coronavirus infection are hepatotoxic. In this article, we analyze data on the impact of COVID-19 on liver function, as well as on the course and outcome of COVID-19 in patients with liver disease, including hepatocellular carcinoma, or those on immunosuppressive therapy after liver transplantation.

Recommendations of the Ministry of Health of the Russian Federation on the formation of a temporary staff table of a medical organization providing medical care to citizens with coronavirus infection COVID-19

2020 ◽  
pp. 5-12
Author(s):  
Olga Shinkareva
Keyword(s):  
Medical Care ◽  
Russian Federation ◽  
Medical Organization ◽  
Ministry Of Health ◽  
Organization Of Work ◽  
Coronavirus Infection ◽  
The Russian Federation

Article is devoted to the analysis of the Order of the Russian Ministry of Health of 19.03.2020 № 198n (an edition of 29.04.2020) “About a temporary order of the organization of work of the medical organizations for implementation of measures for prevention and reduction of risk of spread of a new koronavirusny infection of COVID19” regarding formation of the temporary staff list of the division of the medical organization providing medical care to citizens with a koronavirusny infection of COVID-19 and also the requirement with the staff of this division. The criteria recommended by the Ministry of Health of the Russian Federation for determining the number of rates of medical workers in these divisions, requirements for medical workers of the division have been considered, a practical example of calculation of rates has been given.

Characteristics, outcomes, and risk factors of ICANS after axicabtagene ciloleucel: Does age matter?

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e19556-e19556
Author(s):  
Kitsada Wudhikarn ◽  
Radhika Bansal ◽  
Arushi Khurana ◽  
Matthew Hathcock ◽  
Michael Ruff ◽  
...  
Keyword(s):  
Risk Factors ◽  
Risk Factor ◽  
Older Patients ◽  
Clinical Course ◽  
International Prognostic Index ◽  
Age Groups ◽  
Central Nervous System Involvement ◽  
Microvascular Disease ◽  
B Cell Lymphoma ◽  
Younger Patients

e19556 Background: CD19 chimeric antigen receptor T cell therapy possesses unique side effects including cytokine release syndrome (CRS) and immune effector cell associated neurotoxicity syndrome (ICANS). Age is a major risk factor for ICANS. However, whether ICANS in older patients is different compared to younger patients is unknown. Herein, we report clinical course, outcomes and risk factors for ICANS in older patients with large B cell lymphoma (LBCL) treated with axicabtagene ciloleucel (axi-cel). Methods: We comprehensively reviewed detailed clinical courses of ICANS in 78 adult patients with LBCL treated with axi-cel between June 2016 and October 2020. Incidence, manifestation, risk factors, treatment, and outcomes of ICANS were compared between patients age ≥60 (n=32) and <60 (n=46) years old. Results: Baseline characteristics were comparable between older and younger patients except higher proportion of high international prognostic index and underlying cerebral microvascular disease in older patients. ICANS was observed in 16 patients in the older and 24 patients in the younger age group, with a 30-day incidence of 52% and 50%, respectively. Median time to CRS and ICANS were similar between 2 age groups. The most common initial neurological findings included aphasia, dysgraphia and encephalopathy in both age groups. Table summarizes the characteristics, clinical course and interventions of ICANS in older and younger patients. In Cox regression model, the presence of CRS was the only factor associated with ICANS in both age groups. Age, history of central nervous system involvement and cerebral microvascular disease were not associated with ICANS. Importantly, all patients had complete resolution of ICANS. No elderly patients in our cohort experienced seizure as a manifestation of ICANS. Conclusions: In our study, older age was not a risk factor for ICANS. CRS was the only factor associated with ICANS in both younger and older patients. Incidence, clinical course and neurological outcomes of ICANS in older patients treated with axi-cel were comparable to younger patients. [Table: see text]

Sign in / Sign up

Export Citation Format

Share Document